Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by Annayyaon Jun 07, 2021 12:56pm
136 Views
Post# 33340742

RE:RE:Mackey leads the way ...

RE:RE:Mackey leads the way ...This is a perfect time for the Covid serology news. There is an outbreak in UK with the delta (India) variant which is 40% more transmissible than then UK Variant. If we round it all up, the delta Variant is about 100% more transmissible than the original virus from China. 

[url=https://www.abc.net.au/news/2021-06-06/delta-covid-19-variant-40-per-cent-more-transmissible/100194476 ][/url]

[url=https://theconversation.com/amp/whats-the-delta-covid-variant-found-in-melbourne-is-it-more-infectious-and-does-it-spread-more-in-kids-a-virologist-explains-162170 ][/url]

M101 wrote: Volume is good but not spectacular, this was priced-in late March. I'm with RC, this alone is worth maybe 3 cents, especially after the shelf filing last week. If there's an afternoon rally today I look for it to be sold out within the week unless the company adds news. 




<< Previous
Bullboard Posts
Next >>